XML 61 R27.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Revenue Recognition (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Revenue from Contract with Customer [Abstract] |
Schedule of Timing of Revenue Recognition | The following table illustrates the timing of the Company’s revenue recognition patterns:
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022
Software products and services – point in time | 51.4 | % |  | 49.1 | % |  | 47.3 | %
Software products and services – over time | 35.5 |  |  | 24.3 |  |  | 27.6 |
Drug Discovery – point in time | 6.8 |  |  | 12.7 |  |  | 8.8 |
Drug Discovery – over time | 6.3 |  |  | 13.9 |  |  | 16.3 |
Schedule of Revenue Recognized from the Sources of Software Products and Services Revenue | The following table presents the revenue recognized from the sources of software products and services revenue:
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022
On-premise software | $ | 104,020 |  |  | $ | 104,511 |  |  | $ | 84,487 |
Hosted software | 35,253 |  |  | 20,381 |  |  | 14,890 |
Software maintenance | 23,279 |  |  | 23,066 |  |  | 19,996 |
Professional services | 9,797 |  |  | 9,366 |  |  | 15,205 |
Revenue from contracts with customers | 172,349 |  |  | 157,324 |  |  | 134,578 |
Software contribution | 8,016 |  |  | 1,800 |  |  | 1,000 |
Total software revenue | $ | 180,365 |  |  | $ | 159,124 |  |  | $ | 135,578 |
The following table presents the revenue recognized from the sources of drug discovery revenue:
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022
Drug discovery services revenue from contracts with customers | $ | 25,143 |  |  | $ | 54,720 |  |  | $ | 43,427 |
Drug discovery contribution | 2,031 |  |  | 2,822 |  |  | 1,950 |
Total drug discovery revenue | $ | 27,174 |  |  | $ | 57,542 |  |  | $ | 45,377 |
Schedule of Contract Balances | Contract balances were as follows:
| As of December 31, 2024 |  | As of December 31, 2023
Contract assets | $ | 16,564 |  |  | $ | 21,107 |
Deferred revenue, short-term: |  |  |
Software products and services | 75,660 |  |  | 44,218 |
Drug discovery | 36,284 |  |  | 12,013 |
Deferred revenue, long-term: |  |  |
Software products and services | 14,393 |  |  | 2,407 |
Drug discovery | 94,421 |  |  | 6,636 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of expected timing for satisfying remaining performance obligation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(1) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration